The Latest Cardiac and Vascular News
Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) today announced that it had filed a preliminary information statement with respect to a proposed a reverse stock split of its common stock at a ratio of between 1 for 100 and […]
ATLANTA, Oct. 30, 2019 /PRNewswire/ — Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase on a non-GAAP constant currency basis, both compared to the third quarter of 2018 On-X® revenues increased 12%, and 12% on […]
COPENHAGEN, Denmark, Oct. 31, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform. The EU grant is for an SME Instrument, Phase 2 under the Horizon2020 […]
SUNNYVALE, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2019. “Our third quarter results reflect strong execution across our entire organization,” […]
– Revenue increased 45% year over year to $11.8 million – Orders increased 95% year over year – Net income $2.0 million; Diluted EPS $0.06 – Adjusted EBITDA $2.8M – Thirteenth consecutive quarter of positive net income ENGLEWOOD, Colo., Oct. 29, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing […]
Westport, CT, Oct. 29, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company appointed Mr. […]
WALTHAM, Mass.–(BUSINESS WIRE)–At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of August 7, 2019, by and among Siemens Medical Solutions USA, Inc. (“SMS USA”), Corpus […]
WARRINGTON, Pa., Oct. 25, 2019 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today provided updates on its lead development programs and business operations. “During the third quarter, we made substantive progress in […]
IRVINE, Calif., Oct. 23, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended September 30, 2019. Third Quarter and Recent Highlights Sales grew 21% to $1.1 billion; underlying1 sales grew 19% TAVR sales grew 26%; […]
MARLBOROUGH, Mass., Oct. 23, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.707 billion during the third quarter of 2019. This represents growth of 13.1 percent on a reported basis, 14.2 percent on an operational1 basis and 9.3 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP earnings […]
